Get the Stockscreener App
266.57
3.90%
10.01
After Hours:
266.57
Insulet Corporation stock is traded at $266.57, with a volume of 1.18M.
It is up +3.90% in the last 24 hours and down -0.00% over the past month.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
See More
Previous Close:
$256.56
Open:
$256.56
24h Volume:
1.18M
Relative Volume:
2.15
Market Cap:
$18.70B
Revenue:
$1.98B
Net Income/Loss:
$420.90M
P/E Ratio:
155.89
EPS:
1.71
Net Cash Flow:
$218.20M
1W Performance:
-1.03%
1M Performance:
-0.00%
6M Performance:
+33.75%
1Y Performance:
+28.18%
1-Day Range:
$256.56
$270.70
1-Week Range:
$254.79
$271.18
52-Week Range:
$160.19
$279.77
Insulet Corporation Stock (PODD) Company Profile
Name
Insulet Corporation
Sector
Industry
Phone
978-600-7000
Address
100 NAGOG PARK, ACTON, MA
Compare PODD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
266.57 | 18.70B | 1.98B | 420.90M | 218.20M | 5.84 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-06-24 | Initiated | Bernstein | Outperform |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-07-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-02-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-21-23 | Upgrade | Citigroup | Neutral → Buy |
| Aug-21-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-01-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-19-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Jul-28-20 | Initiated | Wells Fargo | Overweight |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-03-20 | Initiated | BofA/Merrill | Neutral |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-10-19 | Initiated | CFRA | Sell |
| Oct-23-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-14-19 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-04-19 | Downgrade | UBS | Buy → Neutral |
| Oct-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-06-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-10-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-06-19 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Feb-22-18 | Reiterated | Barclays | Overweight |
| Jan-08-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-03-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-15-17 | Initiated | Barclays | Overweight |
View All
Insulet Corporation Stock (PODD) Latest News
The Most Significant Trade Secrets Cases Of 2024 - Law360
Executive VP Of Insulet Sold 26% Of Their Shares - Simply Wall St
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Insulet Co. (NASDAQ:PODD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Here's Why Insulet (NASDAQ:PODD) Can Manage Its Debt Responsibly - Simply Wall St
Insulet corp EVP Benjamin Eric sells $1.17 million in shares By Investing.com - Investing.com Australia
Insulet corp EVP Benjamin Eric sells $1.17 million in shares - Investing.com India
Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today - Benzinga
Stocks Fall As Breadth Remains Weak; Fortinet, Insulet, Embraer In FocusVideoIBD - Investor's Business Daily
Virtu Financial LLC Makes New $616,000 Investment in Insulet Co. (NASDAQ:PODD) - MarketBeat
Toronto Dominion Bank Buys 3,117 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Co. (NASDAQ:PODD) Stake Raised by Geode Capital Management LLC - MarketBeat
Insulet's SWOT analysis: tubeless pump maker's stock faces competition - Investing.com
Why Insulet (PODD) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Insulet Co. (NASDAQ:PODD) Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat
Orion Portfolio Solutions LLC Purchases 3,623 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet stock soars to 52-week high, reaching $279.42 - Investing.com India
RMD or PODD: Which Is the Better Value Stock Right Now? - Yahoo Finance
Insulet stock soars to 52-week high, reaching $279.42 By Investing.com - Investing.com UK
National Bank of Canada FI Decreases Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet corp executive sells $252,192 in common stock By Investing.com - Investing.com Nigeria
Insulet corp executive sells $252,192 in common stock - Investing.com India
Should You Continue to Retain Insulet Stock in Your Portfolio Now? - MSN
Tandem Diabetes (TNDM) and Insulet (PODD) Volatility Attributed to Channel-Check Firm - StreetInsider.com
Google Takes Quantum Leap But Growth Weak Again; AppLovin, Insulet In Focus TooVideoIBD - Investor's Business Daily
Quantinno Capital Management LP Acquires 7,270 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Bought by Nomura Asset Management Co. Ltd. - MarketBeat
3,459 Shares in Insulet Co. (NASDAQ:PODD) Purchased by SGL Investment Advisors Inc. - MarketBeat
Insulet Co. (NASDAQ:PODD) Position Trimmed by Groupama Asset Managment - MarketBeat
XTX Topco Ltd Acquires Shares of 6,351 Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet successfully defends its Intellectual property against EOFlow - Medical Buyer
Insulet wins $452M in lawsuit against rivals over medical device trade secrets - Cardiovascular Business
Jury awards Insulet $452M against Eoflow in trade secrets case - BioWorld Online
Insulet wins $452M in trade secret case By Investing.com - Investing.com Australia
Insulet Wins $452M Trade Secrets Verdict Against EOFlow - USA Herald
Readystate Asset Management LP Trims Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case - Reuters
Insulet Wins $452M Jury Verdict in Trade Secrets Battle with EOFlow - USA Herald
Insulet awarded $452M in EOFlow patent fight - MedTech Dive
Insulet Wins $452 Million in Insulin Pump Trade Secrets Trial - Bloomberg Law
Insulet's Legal Win Against EOFlow Over Trade Secret Theft - Finimize
BREAKING: Insulet Corp. Wins $452M In Trade Secret Theft Trial - Law360
Insulet Wins $452 Million Trade Secret Victory Against EOFlow - MPO-mag
Insulet Corporation (PODD) Secures Major Legal Victory with $452 Million Jury Award - GuruFocus.com
Insulet wins $452M in trade secret case - Investing.com India
Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court - Business Wire
Insulet Co. (NASDAQ:PODD) Shares Sold by Parkman Healthcare Partners LLC - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Sold by The Manufacturers Life Insurance Company - MarketBeat
Beacon Investment Advisory Services Inc. Has $37.84 Million Stock Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
70,213 Shares in Insulet Co. (NASDAQ:PODD) Acquired by Caisse DE Depot ET Placement DU Quebec - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Buys 5,031 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Corporation Stock (PODD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):